WallStSmart

CF Industries Holdings Inc (CF)vsICL Israel Chemicals Ltd (ICL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ICL Israel Chemicals Ltd generates 0% more annual revenue ($7.41B vs $7.41B). CF leads profitability with a 23.7% profit margin vs 3.5%. CF appears more attractively valued with a PEG of 3.25. CF earns a higher WallStSmart Score of 75/100 (B).

CF

Strong Buy

75

out of 100

Grade: B

Growth: 6.7Profit: 9.0Value: 7.3Quality: 8.0
Piotroski: 6/9Altman Z: 2.37

ICL

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 5.0Value: 3.3Quality: 5.5
Piotroski: 2/9Altman Z: 2.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CFUndervalued (+49.7%)

Margin of Safety

+49.7%

Fair Value

$217.58

Current Price

$117.54

$100.04 discount

UndervaluedFair: $217.58Overvalued
ICLSignificantly Overvalued (-24.5%)

Margin of Safety

-24.5%

Fair Value

$4.62

Current Price

$5.60

$0.98 premium

UndervaluedFair: $4.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CF6 strengths · Avg: 9.5/10
P/E RatioValuation
9.9x10/10

Attractively priced relative to earnings

Return on EquityProfitability
32.9%10/10

Every $100 of equity generates 33 in profit

Operating MarginProfitability
33.6%10/10

Strong operational efficiency at 33.6%

EPS GrowthGrowth
115.1%10/10

Earnings expanding 115.1% YoY

Profit MarginProfitability
23.7%9/10

Keeps 24 of every $100 in revenue as profit

Revenue GrowthGrowth
19.4%8/10

19.4% revenue growth

ICL2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
39.5%8/10

Earnings expanding 39.5% YoY

Areas to Watch

CF1 concerns · Avg: 2.0/10
PEG RatioValuation
3.252/10

Expensive relative to growth rate

ICL4 concerns · Avg: 3.3/10
P/E RatioValuation
26.6x4/10

Moderate valuation

Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
3.5%3/10

3.5% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CF

The strongest argument for CF centers on P/E Ratio, Return on Equity, Operating Margin. Profitability is solid with margins at 23.7% and operating margin at 33.6%. Revenue growth of 19.4% demonstrates continued momentum.

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth. Revenue growth of 14.5% demonstrates continued momentum.

Bear Case : CF

The primary concerns for CF are PEG Ratio.

Bear Case : ICL

The primary concerns for ICL are P/E Ratio, Return on Equity, Profit Margin. Thin 3.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

CF profiles as a growth stock while ICL is a value play — different risk/reward profiles.

ICL carries more volatility with a beta of 0.95 — expect wider price swings.

CF is growing revenue faster at 19.4% — sustainability is the question.

CF generates stronger free cash flow (273M), providing more financial flexibility.

Bottom Line

CF scores higher overall (75/100 vs 59/100), backed by strong 23.7% margins and 19.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CF Industries Holdings Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

CF Industries Holdings, Inc. is a North American manufacturer and distributor of agricultural fertilizers, based in Deerfield, Illinois.

Visit Website →

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Want to dig deeper into these stocks?